ML20055A910
| ML20055A910 | |
| Person / Time | |
|---|---|
| Site: | Waterford  |
| Issue date: | 07/16/1982 |
| From: | Sherwin Turk NRC OFFICE OF THE EXECUTIVE LEGAL DIRECTOR (OELD) |
| To: | Atomic Safety and Licensing Board Panel |
| References | |
| NUDOCS 8207200118 | |
| Download: ML20055A910 (14) | |
Text
,
ISSIGMATED ORIGIMADg Certified Dr
/ 07/16/82 Dso7 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE ATOMIC SAFETY AND LICENSING BOARD In the Matter of )
)
LOUISIANA POWER AND LIGHT COMPANY ) Docket No. 50-382 (Waterford Steam Electric Station, Unit 3) )
NRC STAFF'S SUPPLEMENTAL MOTION TO CORRECT THE HEARING TRANSCRIPT Pursuant to 10 C.F.R. 55 2.730(a) and 2.750(b), the NRC Staff
(" Staff") hereby moves to correct the official transcript of the hearing held in New Orleans, Louisiana, on March 23 - April 2 and May 3-12, 1982
(" Transcript"). In support hereof, the Staff states as follows:
- 1. The Staff has reviewed tne Transcript and has identified a number of corrections which the Staff considers to be necessary in order to more accurately reflect the statements made at the hearing. Those suggested corrections are set forth in Appendix A to the "NRC Staff's Motion to Correct the Hearing Transcript," filed on July 15, 1982
(" Motion").
- 2. The Staff has now determined that a further correction to the Transcript, not identified in Appendix A to the Staff's Motion of July 15, 1982 is required in order to accurately reflect the evidence presented before the Licensing Board. This further correction is set forth in
" Appendix AA" which is attached hereto and incorporated by reference herein.
8207200110 820716 g 587 PDR ADOCK 05000392 G PDR
O
- 3. The additional correction identified herein is required for the following reasons. As set forth at pp. 2094 and 2097-98 of the Transcript, the witness (Dr. Campbell) was shown a copy of the 1981
" Facts and Figures" pamphlet published by the American Cancer Society.
In particular, the witness' attention was called to page 10 of that publication and was asked to identify the figure which appears on that page next to the entry for the United States. While the Transcript indicates that the cross-examiner recited the number "180", the publication itself, to which both the cross-examiner and the witness were referring, contains the number "188". A copy of pages 1-10 of that publication is attached hereto as " Attachment BB".
WHEREFORE,pursuantto10C.F.R.SQ2.730(a)and2.750(b),the Staff hereby moves to correct the Transcript as set forth herein, which correction shall be included in the record as an Appendix to the Transcript.
Respectfully submitted, y crA Sherwin E. Turk Counsel for NRC Staff Dated at Bethesda, Maryland this 16th day of July, 1982
'O' e
' APPENDIX AA SUPPLEMENTAL CORRECTION TO THE TRANSCRIPT OF THE HEARING PAGE LINE DELETE INSERT 2098 21 180 188
^^
\
ATTR CH MEDT*B8" -
g e han Cancer Society kNCER E '
CTS & FIGURES -
~ .. .z.
'W ' 4' ....Yhb.YN ~
.. % (ghk.
. k',5 L'k.*]
2,500 2,000 '!;
13,000 ,
-z f '
,400 7,000 31, 2,500 1,100 11,000 49'# .
I 5,500 19,000 l
@,300
' 000 42,000 200 ... 1
\
8,400 19,000 g 17 # -
19,000 16,W 11,000 8,6 %
9,#
8,100 3,,g0 8,3% - ' s-13,000 16,000 ' -
41,000
<. "%v 3
an g
w j -
1'
'. ..: . : - Eh '
,. J.Li < . .- .
b '
^
b 600 sJ . w /.' .
^ '
, 7 _
ALASKA J;7- MAW ~ ' -
- .~,a yan n M 7
$Xs3 l
% 9l W j
, r,sh'JA@I.0 fuoo. .
k hd.g.
- atima.o m>= a n g . .
$ ' cancer casesin 1981 by states '" , - ~^
M ~ ON* ,
====aaw.n=r
. OONTENTS AME RICAN CANCE R SOCIETY . . . . . . . . .19 CHARTERED DIVISIONS OF THE B AS I C D ATA . . . . . . . . . . . . . . . . . . . . . . . . . 3 AMERICAN CANCER l Definition, treatment, incidence, SOCI ETY, I NC.. . . . . . . . . . . . . . . Back Cover -
survival, mortality, prevention CELE BRITIES AN D CANCE R. . . . . . . . . . . 29 l BLACKS AND WHITES, CANCER RATES . . 5 COMPREHENSIVE CANCER CENTERS... 31 j BUDGET ALLOCATIONS . . . . . . . . . . . . . . 27 COSTS O F CAN CE R . . . . . . . . . . . . . . . . . . 28 i CANCE R SITES . . . . . . . . . . . . . . . . . . . 14 19 E N V I R O N M E N T . . . . . . . . . . . . . . . . . . 26-27 B r ea s t . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Cancer Prevention Study. . ............ 26 Cancer in Children. . . . . . . . . . . . . . . . . . . . 18 Studies of Occupational Groups . . . . . . . . . 26 Colo n-R ectu m . . . . . . . . . . . . . . . . . . . . . . . 16 GUIDELINES FOR CHECKUPS. . . . . . . . . . 30 Leu kemia . . . . . . . . . . . . . . . . . . . . . . . . . . 18 H OW CAN CE R WO R KS . . . . . . . . . . . . . . . . . 4 Lung..............................14 INCIDENCE AND MORTALITY Oral...............................17 STATISTICS, SOU RCES . . . . . . . . . . . . . . . 4 Skin...............................17 PU B LIC E DUCATION . . . . . . . . . . . . . . . . . 19 U t e r u s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 PROFESSIONAL EDUCATION . . . . . . . 20 21 CH ARTS AN D TABLES. . . . . . . . . . . . . . 7-13 Clinical Fellowships. . . . . . . . . . . . . . . . . . . 20 1981 Estimated New Cases Clinical Professorships. . . . . . . . . . . . . . . . . 21 by States . . . . . . . . . . . . . . . . . . . Front Cover Unproven Methods of Cancer Management. 21 Mortality for Leading Causes R E S E A R C H . . . . . . . . . . . . . . . . . . . . . . 23-2 5 of Death: 1977. . . . . . ............... 7 Kinds of G rants . . . . . . . . . . . . . . . . . . . . . 23 Five-year Survival Rates for Selected Sites . . 7 The Financial Research Picture. . . . . . . . . . 24 1981 Estimated Cancer incidence Table of Funded and Unfunded Grants. . . . 24 by Site and Sex . . . . . . . . . . . . . . . . . . . . . . 7 ACS-Supported Nobelists . . . . . . . . . . . . . . .25 1981 Estimated Cancer Deaths Current Researchers . . . . . . . . . . . . . . . . . . 25 by Site and Sex . . . . . . . . . . . . . . . . . . . . . . 7 SERVICE AND REHABILITATION . . . 21-23 1981 Estimated New Cancer Cases, S e rv ic e. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Deaths by Sex for all Sites. . . . . . . . . . . . . . 8 R ehabilitatio n . . . . . . . . . . . . . . . . . . . . . . . 22 1981 Estimated New Cases, All Sites S M O K I N G . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 b y S t a te. . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 SOURCES OF INCOME . . . . . . . . . . . . . . . . 28 1981 Estimated Cancer Deaths, TRENDS IN DI AGNOSIS All Sites by State. . . . . . . . . . . . . . . . . . . . 10 AN D T R E ATM E NT . . . . . . . . . . . . . . . . . 5-6 Female Cancer Death Rates by Site. . . . . . .11 WA R N I N G SI G N A LS . . . . . . . . . . . . . . . . . . 20 Male Cancer Death Rates by Site. . ......11 25 Year Trends in Age Adjusted ,
Cancer Death Rates. . . . . . . . . . . . . . . . . . 11 Mortality for 5 Leading Sites i by Age G roup, Sex . . . . . . . . . . . . . . . . . . 12 How to Estimate Cancer Statistics Locally .12 Cancer Around the World . . . . . . . . . . . . . . 13 l
l l
l l
l C 1980 American Cancer Society, Inc. All rights reserved, including the right to reproduce this publication or portions thereof in any form. For written permission, address American Cancer Society,777 Third Avenue, New York. N.Y.10017 1
l l
l I
1
i
)
BASIC DATA What is cancer? be followed much longer than five years.
Cancer is a large group of diseases characterized How many new cases will there be this year?
by uncontrolled growth and spread of abnormal cells. If the spread is not controlled or checked,it In 1981 about 805,000 people will be diagnosed ;
i
.; results in death. However, many cancers can be as having cancer., -
cured if detected and treated promptly.
How many people are surviving cancer?
How .s cancer treated? About 268,000 Americans, or about one-third of ,
. all people who get cancer this year, will be ahve at
, By surgery, X rays, radioactive substances, chem- least five years after treatment. However, when nor-scals, hormones and immunotherapy.
mal life expectancy is taken into consideration (fac-tors such as dying of heart disease, accidents and Has there been any progress against cancer? diseases of old age),41% of cancer patients will sur-Yes. In the early 1900's few cancer patients had vive at least five years.
any hope of long-term survival. In the 1930's less than one in five was alive at least five years after Could more people be saved?
treatment. In the 1940's it was one in four. Now the Yes. About 134,000 people with cancer will ratio is one in three. The gain from one in four to probably die in 1981 who might have been saved by one in three currently represents about 67,000 earlier diagnosis and prompt treatment.
people this year.
How many people will die?
Who gets cancer? This year about 420,000 will die of the disease -
Cancer strikes at any age. It kills more children 3 1,150 people a day, about one every 75 seconds. Of to 14 than any other disease. And cancer strikes every five deaths from all causes in the U.S., one is more frequently with advancing age. from cancer. In 1980 an estimated 412,000 Ameri-cans died of cancer. In 1979 it was 404,000. In How many people alive today will ever get cancer? 1978, it was 396,992. In 1977, 386,686 cancer Almost 56 million Americans now living will deaths were reported by the U.S. National Center eventually have cancer; one in four, according to for Health Statistics, present rates. Over the years, cancer will strike in approximately two of three families. In the 70's, What is the national death rate?
there were an estimated 3.5 million cancer deaths, There has been a steady rise in the age-adjusted **
over 6.5 million new cancer cases, and more than 10 national death rate. In 1930 the number of cancer million people under medical care for cancer. deaths per 100,000 population was 143. In 1940 it was 152. By 1950 it had risen to 158 and in 1977 How many people alive today have ever had cancer? the number was 175. Except for cancer of the lung, l There are over 3 million Americans alive today age-adjusted cancer death rates for major sites in who have a history of cancer,2 million of them with general are leveling off and in some cases declining.
diagnosis five or more years ago. Most of these 2 million can be considered cured, while others stilj Can cancer be prevented?
have evidence of cancer. By " cured"is meant that a Some cancers,. not all. Most lung cancers are patient remains free of disease and has the same life caused by cigarette smoking, and most skin cancers expectancy as a person who never had cancer, by frequent overexposure to direct sunlight. These The decision as to when a patient may be con- cancers can be prevented by avoiding their causes.
] sidered cured is one that must be made by the phy- Certain cancers caused by occupational /environmen-l sician after examining the individual patient. For tal factors can be prevented by eliminating or reduc-most forms of cancer, five years without symptoms ing contact with carcinogenic agents. Examples in-following treatment is the accepted time. However, clude bladder cancer among workers in the dye in-some patients can be considered cured after one dustry, and lung cancer in asbestos workers - espec-year, others after three years, whereas some have to ially those who are also smokers.
'These estimates of the incidence of cancer are based upon data from the National Cancer Institute's SEER Program (1973-1977). Non-melanoma skin cancer and carcinoma in situ have not been included in the statistics.The incidence of non-melanoma skin cancer is estimated ta be about 400,000.
t " Age-adjusted - a method used to make valid statistical comparisons by assuming the same age distribution among different groups being compared.
3 t ~ _ . -- - - _ _ _ -
SOURCES OF NCIDENCE AND MORTALITY STATISTICS INCIDENCE Cancer in most parts of the United States is demintnw w 9..' Mi>.
Begin'n'ing with the 1979 edition of Facts &
not knowinga reportable disease.
exactly how many Thus new cases thereareis no way of { Figures, SEER incidence informatio of cancer diagnosed each year. In the past, estimates of cancer The latest available information for this 1981 edi-incidence were made by extrapolating from the tion is from the years 1973-1977. Each time a new experience of the few population-based cancer data base is introduced to estimate incidence, registries. there may be sharp changes in figures due to the In 1969, the National Cancer Institute embarkedL more accurate data.phey oo not mancate a cancer on a three-year survey of cancer incidence in nine epidemic or new cmc.
major areas of the United States. It was the most Since comparisons of figures from different comprehensive incidence survey ever carried out. data bases are not valid, one can compare the 1978 Then in 1973, NCI began a new and larger program, Facts & Figures only with the previous editions, and gathering data from 11 population-based registries. the 1979 Facts & Figures only with later editions.
It is called SEER, standing for Surveillance, Epi-i
, MORTALITY l
, There has been no change in the data base for However, to increase accuracy, mortality rates i
mortality statistics. The source is the National per 100,000 population have been age-adjusted for Center for Health Statistics, Department of Health the first time to the 1970 census, rather than to the and Human Services. 1940 census. For these population-based mortality The 1981 figures are estimates based on the lat- rates alone, comparing charts and figures with those est available information, which includes material of previous years may indicate false trends.
through 1977.
HOW CANCEliWORKS Normally, the cells that make up the body re- imade neighboring organs or tissue by direct exten-produce themselves in an orderly manner so that sion of growth or they become detached and are worn-out tissues are replaced, injuries are repaired carried through the lymph or blood systems to oth-and growth of the body proceeds. er parts of the body.
Occasionally, certain cells undergo an abnormal This spread may be regional-confined to one change and begin a process of uncontrolled growth region of the body-when cells are trapped by and spread: one cell divides into two, those redivide lymph nodes. If left untreated, however, the cancer into four, and so on. These cells may grow into is likely to spread throughout the body. This is ad-masses of tissue called tumors - some benign and vanced cancer, and usually results in death.
others malignant (cancer). Because with each stage a case of cancer becomes The danger of cancer is that it invades and de- progressively more serious,it is important to detect stroys normal tissue. At the beginning, cancer cells cancer as early as possible. Aids to early detection usually remain at their original site, and the cancer include cancer's Seven Warning Signals and the can-is said to be localized. Later, some cancer cells may cer risk factors. (See Under Individual Sites.)
4
CANCER RATESIN BLACK 9 AND WHITES
- A study of cancer rates over several decades double that in whites. However, the rate for endo-shows that the cancer incidence rate for blacks is metrial cancer - or cancer of the body of the uterus higher than for whites, and that blacks also have a - for white women is double that of black women.
higher death rate than whites. Survival for patients diagnosed between 1967 and Male cancer incidence and mortality ratesin each 1973 was compared. More whites than blacks had race increased while female rates decreased. cancer diagnosed in an early, localized stage when The overall cancer incidence rate for blacks went the chances of cure are best: 37 versus 28% for up 8% while for whites it dropped 3%. Cancer mor- males, and 42 versus 31% for women.
tality for blacks is greater than for whites. Most of the differences in black and white cancer Cancer sites where blacks had significantly higher rates were attributed to environmental and social
] increases in incidence and mortality rates included factors rather than to inherent biological character-I the lung, colon-rectum, prostate and esophagus. istics. Because a higher percentage of blacks than Esophageal cancer, long considered mainly a disease whites are in the lower socio-ecanomic group, risk of males, declined in whites and rose rapidly in of exposure to industrial carcinogens may be in-blacks of both sexes. creased. Also, limited educational opportunities may The incidence of invasive cancer of the uterine prevent early detection as the less educated are less cervix dropped in both black and white women, al- likely to know the importance of symptoms which though the incidence in blacks is still more than could lead to an early diagnosis.
TRENDS IN DIAGNOSIS AND TREATMENT Cancer management today is becoming increasing-
- Interferon, a natural body substance known to ly individualized both with respect to diagnostic combat viruses, has shown promise in preliminary procedures and treatment. Early detection is follow- research on advanced human cancers of the bone, ed by a precise staging of the disease, and the use of breast and lymphatic system.
more than one kind of therapy, often in combi-
- Retinoids, synthetic " cousins" of Vitamin A, nation. have prevented bladder and breast cancers in mice The following 14 cancers a few decades ago had and rats, and may also work against cancers of the very poor prognoses - today they are being cured in lung, esophagus and pancreas in humans.
many cases, predominantly because of chemother-
- About fifty drugs have been found effective apy advances: acute lymphocytic leukemia, adult against certain cancers, and others that are still myelogenous leukemia, Hodgkin's disease, histio- being tested hold promise.
cytic lymphoma, Burkitt's lymphoma, nodular
- Surgery now is more precise than in the past be-mixed lymphoma, Ewing's sarcoma, Wilms' tumor, cause of improved diagnostic equipment and laser thabdomyosarcoma, choriocarcinoma, testicular instruments, and rehabilitation is improved cancer, ovarian cancer, breast cancer, osteogenic through advances in plastic surgery.
j sarcoma. Other cancers are being more effectively
- Experiments have been conducted with simple, controlled than in the past. inexpensive blood tests, based on unique chemical O
h An outstanding example of progress is the im- substances, to determine whether an individual provement in the management of Hodgkin's disease has cancer and where it is. Good preliminary re-(a cancer of lymph glands in predominantly young sults have been obtained in selected cases by using l
adults). Better disease staging in certain cases, more the procedures to detect cancers of the breast, l
precise application of new and improved x-ray pancreas and other sites.
L h therapy and/or a combination of four cancer drugs
- Intense drug therapy before surgery has been suc-
[ has resulted in remarkably improved survival. In cessful in the treatment of children with bone less than 10 years, the flye-year survival rate for tumors,and is being adapted to help fight some of early cases rose from 68 to 90%, and from 10 to the more common cancers in adults.
70% for advanced cancer.
- A series of chemical injections near the spine can J
The following developments indicate the direc- act as a nerve block, relieving certain cancer tions of current and future research: patients of debilitating pain.
' Figures for cancer incidence are frorn the National Cancer Institute National Surveys,1947 and 1969; those for cancer rnortality from the National Center for Health Statistics, 1952 1977.
5
e Common denominator approaches to cancer pre-
- Immunotherapy holds hope of harnessing the vention may include the study and manipula- body's own disease-fighting systems to combat tion of "oncogenes" - cancer-causing genes cancer with essentially no overt toxicity. In lab-which normally are dormant but which may be oratory animals, substances such as BCG can stim-activated by radiation, chemicals and viruses. ulate immune mechanisms. These substances now Researchers have learned how to suppress onco- are being used in humans alone or with other genes in some animals, and are determining forms of treatment.
whether the same thing can be done in humans. e Because environmental factors have been found e A new technique makes high and potentially for virtually every major cancer, it is becoming lethal doses of the cancer drug, methotrexate, possible to " profile" individuals according to safe and effective for the treatment of some their cancer risk factors, and therefore select the cancers. most appropriate time for diagnostic tests.
e flyperthermia (the superheating of body tissues) e The transfusion of blood componentsis becoming is being used to increase the effectiveness of increasingly available and effective for cancer radiotherapy and chemotherapy. therapy. Platelets are used to prevent hemorrhag-e Many patients with bone cancer now are treated ing and white cells to treat infection as well as the successfully by removing and replacing a section cancer itself.
of bone rather than by amputating the leg or arm.
- Computerized tomography uses X rays to exam-Drugs and radiatiort therapy also are being used ine the brain and other parts of the body. Cross-effectively following surgery, resulting in dra- section pictures are constructed which show a matic improvement in survival. tumor's shape and location more accurately than e liigh-frequency sound waves (ultrasound),instead is possible with conventional x-ray techniques.
of X ray i, are being used to locate tumors deep e Many cancers are caused by a two-stage process in the '.,tdy. For patients undergoing radiation through exposure to two different kinds of sub-therapy, ultrasound may enable the therapist to stances known as initiators and promoters. Re-pinpoint the tumor more precisely in order to searchers are exploring ways of interrupting the provide more accurate radiation dosage and 10- process and thereby preventing the development cation of the tumor. of cancers.
l 6
l
_ ._---._.. ._ _ . . . . . . . . ~ _ .-
- - n . ~ .u .. . .-. ..
MORTALITY FOR LEADING CAUSES OF DEATH: FIVE YEAR CANCER SURVIVAL RATES
- UNITED STATES,1977 FOR SELECTED SITES Death Percent O 20 40 40 80 m Number Rate of of Per 100,000 Total SLADDER R es E Deaths Population Deaths Rank Cause of Death g gg BREAST ** :
All Causes 1,899,597 816.3 100.0 1 Diseases of Heart 718,850 303.4 37.8 COLON.
RECTUM M og g 2 Cancer 386.686 168.4 20.4 LARYNX g E4E ""'d 3 Stroke 181,934 75.3 9.6 M 4 Accidents 103.202 45.4 5.4 LUNG 5 Influents & Pneumonia 51,193 21.4 2.7
- 6 Diabetes Melhtus 32,989 14.1 1.7 ORAL 7 Carrhosis of Liver 30,848 14.0 1.6 8 Arteriosclerosis 28,754 12.0 1.5 PROSTATE g 70 %
MMM-M 9 Suicide 28,681 12.6 15 10 Diseases of infancy 23,401 13.0 1.2 C X eos &&:i2 11 Homicide 19,968 8.6 1,1 UTERUS
'8% B 12 Emphysema 16,376 7.1 0.9 CORPUS 2 13 Congenital Anomah 12,983 6.8 0.7 14 Nephritis & Nephrosis 8,519 3.7 0.5 M LOCALIZED E3 REGION AL E5E DISTANT INVOLVEMENT METASTASES 15 Septicemia & Pyemia 7,112 3.2 o,4 Other & lil-defined 248,101 107.3 13.5 Source: Biometry Branch, National Cancer institute.
' Survival rates for this chart and those discussed elsewhere in this Source: Vital Statistics of the United States,1977 booklet are adjusted for normallife expectancy.
1981 ESTIMATES CANCER INCIDENCE BY SITE AND SEX t CANCER DEATHS BY SITE AND SEX SKIN 2% 2% l skin sniN 2% 1% l SKIN ORAL 5%
ORAL 5 % *!0"^'
8 27% l eRE AST 19% l 9RE AST LUNG 22% .' LUNG 34 % A- k[-
LUNG b ;dh
~
1$% l LUNG COLON & COLON & ggg RECTUM 14% REcTUu 9(l
. 15%lgOg4 ;, .: 15%l @ $8 PANCR$A$ 3% PANCREAS 5%
3% l PANcRE A$ 5%l PANCREAS
\ n\ ] 6% l OVARY l[ PROST ATE 17%
[ l 4% l OV ARY PROSTATE
-[
10% .T 13% l UTE RUS x Y'-
f- $% l UTERUS URIN AR Y 9% URIN AR Y 6% b l
f 4% l URINARY 3% l urin ARY l
LEUKEM1 A & gg LE UKEMI A & gg aw.g [dh L Y MPHOM AS LYMPHOMAS LEUKEMI A &
l7 l LEUKEMIA I
I LYMPHOMAS LYMPHOMA3 ALL OTHE R 20% ALL OTHE R M l15% l ALL OTHER l21%l ALL OTHER tEneluding non-melanoma skin cancer and carcinoma in situ.
7 i
a Estimated New Cancer Cases and Deaths by Sex for All Sites - 1981*
ESTIMATED NEW CASES ESTIMATED DEATHS SITE BOTH SEXES MALE FEMALE BOTH SEXES MALE FEMALE All Sites 815,000* 403,000* 412,000* 420,000 227,500 192,500 Buccal Cavity & Pharynx (Oral) 26,600 18,400 8,200 9,150 6,300 2,850 Lip 4,600 4,100 500 175 150 25 Tongue 4,800 3.200 1,600 2,000 1,400 600 Salivary Gland 700 450 250 Floor of Mouth - 9,600 5,700 3,900 525 400 125 Other & Unspecified Mouth 1,550 1,000 550 Pharynx 7,600 5,400 2,200 4,200 2,900 1,300 Digestive Organs 194,500 99,700 94,800 110,500 57,600 52,900 Esophagus 8,800 6,200 2,600 8,100 5,800 2,300 Stomach 23,900 14,500 9,400 13,900 8,400 5,500 Small Intestine 2,100 1.100 1,000 700 350 350 Large intestine , (Colon- 83,000 38,000 45,000 46,200 21,500 24,700 Rectum . Rectum) 37,000 20,000 17,000 8,700 4,700 4,000 Liver & Biliary Passages 13,000 6,000 7,000 9,400 4,600 4,800 Pancreas 24,200 12,700 11,500 22,000 11,500 10,500 Other & Unspecified Digestive 2,500 1,200 1,300 1,500 750 750 Respiratory System 135,800 99,000 36,800 110,100 81,000 29,100 Larynx 10,700 9,000 1,700 3,700 3,100 600 Lung 122,000 88,000 34,000 105,000 77,000 28,000 Other & Unspecified Respiratory 3,100 2,000 1,100 1,400 900 500 Bone, Tissue and Skin 20,900 10,700 10,200 10,050 5,800 4.250 Bone 1,900 1,100 800 1,750 1,000 750 Connective Tissue 4,700 2,600 2,100 1,600 800 800 Skin 14,300** 7,000 * *' 7,300** 6,700t 4,000 2,700 Breast 110,900 900 110,000 37,100 300 36,800 Genital Organs 151,600 75,200 76,400 46,400 22,700 23.700 Cervix, invasive 16,000*** - 16,000*** 7,200 - 7,200 Corpus, Endometrium 38,000 -
38,000 3,100 - 3,100 Ovary 18,000 -
18,000 11,400 - 11,400 Prostate 70,000 70,000 -
22,700 22,700 -
Testis, Other Male Genital 5,200 5,200 -
1,000 1,000 -
Other & Unspecified Genital, Female 4,400 -
4,400 1,000 - 1,000 Urinary Organs 54,600 38,000 16,600 18,700 12,200 6,500 Bladder 37,000 27,000 10,000 10,600 7,300 3,300 Kidney & Other Urinary 17,600 11,000 6,600 8,100 4,900 3.200 Eye 1,800 900 900 400 200 200 Brain & Central Nervous System 12,100 6,700 5,400 10,200 5,600 4,600 1 Endocrine Glands 10,800 3,' 00A~ 7,500 1,500 600 900 Thyroid 9,900 2,800 7,100 1,050 350 700 Other Endocrine 900 500 400 450 250 200 Leukemia 23,400 13,000 10,400 15,900 8,900 7,000 Other Blood & Lymph Tissues 39,500 20,900 18,600 21,600 11,200 10,400 Hodgkin's Disease 7,100 4,100 3,000 1,700 1,000 700 Multiple Myeloma 9,400 4,800 4,600 6,700 3,400 3,300 Other Lymphomas 23,000 12,000 11,000 13,200 6,800 6,400 All Other & Unspecified Sites 32,500 16,300 16,200 28,400 14,100 14,300 Note: The estimates of new cancer cases are offered as a rough guide and should not be regarded as definitive. Esaecially note that l year to year changes may only represent improvements in the basic data. ACS six major sites in boldface.
- Carcinoma in situ and noneelanoma skin cancers not included in totals. Carcinoma in situ of the uterine cervix accounts for over 45,000 new cases annuelty. Non-melanoma skin cancer accounts for about 400,000 new casas annually.
- Melanoma only ** *f nvasive cancer only, tMelanoma 5,000; other skin 1,700 INCIDENCE ESTIMATES ARE BASED ON R ATES FROM N.C.I. SEER PROGRAM 1973 1977 8
a_ _ _ _ _ . _ _ _ _ _ . _
NEW CANCER CASES - 1981 Estimated New Cancer Cases for All Sites Plus Major Sites, by State - 1981 All Sites
- Mejor Sites Number of Female Colon- Uterus State Cases Breast Rectum Lung Oral (Invasive) Prostate Stomach Pencress Leukemia Alabama 13,000 1,600 1,600 2,200 350 1,000 1,100 325 425 400 Alaska 600 50 50 100 15 30 20 15 10 20 Arizona 8,100 1,100 1,100 1,300 275 550 750 175 250 225 Arkansas 8,600 1,000 1,100 1,500 300 600 800 200 300 300 California 79,000 11,200 10,400 12.200 2,000 4,800 6,500 2,500 2,400 2,200 Colorado 7,000 1,000 950 850 175 400 550 175 250 250 Connecticut 13,000 2,100 2,000 1,800 450 750 1,100 400 400 375 Delewsre 2,200 250 300 400 70 150 150 50 50 40 Dist.of Columbia 3,200 450 400 450 200 250 275 90 100 60 Florida 46,000 5,600 6,700 7,500 1.600 2,800 4,400 1,200 1,300 1,200 Georgia 16,000 1,700 1,800 2,600 800 1,200 1,500 400 450 500 Howsii 2,400 250 300 350 100 125 125 175 60 70 ideho 2,500 400 300 350 75 150 250 70 80 100 lilinois 42,000 5,900 6,500 6,300 1,500 2,700 3,400 1,400 1,200 1,200 Indiana 19,000 2,700 2,800 2,900 500 1,700 1,400 450 550 500 lowa 11,000 1,500 2,100 1,500 300 750 1,200 300 350 400 Kansas 8,400 1,200 1,300 1,200 275 650 800 175 300 300 Kentucky 13,000 1.400 1,800 2,300 425 950 1,200 275 375 400 Louisiana 14,000 1,600 1,800 2,300 550 850 1,200 400 400 350 Maine 4,500 600 800 650 150 350 400 150 150 100 Maryland 16,000 2,300 2,100 2,400 650 1,100 1,400 375 400 375 Massachusetts 23,000 3,400 4,100 3,200 900 1,500 1,900 850 650 600
, Michigan 31,000 4,300 4,400 4,700 950 2,200 2,700 850 850 850 Minnesota 13,000 1,800 2,200 1,700 375 800 1,500 500 450 475 Mississippi 8,300 800 950 1,400 250 600 1,100 250 300 300 Missouri 19,000 2,300 3,100 2,900 550 1,400 1,900 500 550 550 Montana 2,500 300 400 350 80 150 275 80 80 80 Nebraska 5,500 750 950 750 150 350 500 175 225 225 Nevada 2,300 300 300 400 60 150 125 15 60 40 New Hampshire 3,300 400 600 500 100 225 275 70 90 100 New Jersey 30,000 4,700 5,000 4,400 1,100 2,100 2,300 1,100 900 750 New Mexico 3,100 350 400 400 60 250 275 80 90 70 New York 72,000 11,200 12,500 9,900 2,600 4,800 5,500 2,800 2,400 2,000 North Carolina 19,000 2,500 2,400 2,800 650 1,400 1,900 400 500 500 North Dakota 2,000 350 350 250 50 100 300 100 80 70 Ohio 39,000 5,700 6,300 6,400 1,300 2,900 3,200 1,200 1,100 1,200
- l. Oklahoma 11,000 1,300 1,400 1,900 375 650 1,000 275 325 325 l Oregon 8,700 1,200 1,200 1,500 250 550 800 200 300 300 Pennsylvania 49,000 7,000 9,100 6,900 1,500 3,200 3,900 1,600 1,300 1,300 Rhode Island 4,500 650 850 600 200 300 400 175 100 80 South Carolina 9,000 1,100 1,100 1,400 350 750 850 175 300 250 South Dakota 2,400 350 400 350 50 150 300 80 90 100 Tennessee 16,000 1,900 2,100 2,700 550 1,100 1,400 325 475 475 Texas 41,000 5,100 5,100 6,700 1,500 2,700 3,500 1,200 1,200 1,300 Utah 2,800 400 400 250 60 200 300 80 80 80 Vermont 1,800 250 300 300 60 150 200 50 50 60 l Virginia 17,000 2,300 2,200 2,700 550 1,100 1,500 400 475 400 Washington 14,000 2,000 1,900 2,100 450 750 1,300 350 400 450 i West Virginia 7,200 850 950 1,100 200 600 600 200 250 175 Wisconsin 17,000 2,400 2,700 2,100 550 950 1,600 600 500 500 Wyoming 1,100 150 150 200 20 70 80 20 30 30 United States 805,000 110,000 120,000 122,000 27,000 54,000 70,000 24,000 24,000 23,000 Puerto Rico 6,000 450 450 350 425 750 400 500 100 175 s
'Does not include carcinoma in situ or non<nelanoma skin concer.
These estimates are offered as a rough guide and should not be regarded as definitive. They are calculated according to the distribution of estimated 1981 cancer deaths by state. Especially note that year-to-year dianges may only represent improvements in the basic data.
9 p - -- . - - .
.__.--,,,g
CANCER DEATHS - 1981 Estimated Cancer Deaths for All Sites plus M:jor Sites, by State - 1981 All Sites Major Sites
- Number Death Rate of per 100,000 Female Colon-Deaths Population Breast Rectum Lung Oral Uterus Prostate Stomach Pancreas Leukemia State Alabama 6,900 181 500 700 1,900 125 200 375 200 375 250 Alaska 300 72 20 30 75 5 10 10 10 10 10 Arizone 4,300 163 325 450 1,100 100 50 225 125 225 150 Arkansas 4,500 200 325 500 1,200 100 100 275 150 250 200 Californie 42,000 185 3,700 5,000 10,500 850 900 2,200 1,500 2,200 1,500 Colorado 3,600 124 325 475 750 70 70 225 125 200 175 Connecticut 6,500 206 650 900 1,500 175 125 325 250 350 250 Delaware 1,100 182 80 150 300 25 20 50 30 60 30 Dist,of Columbia 1,700 250 175 200 375 75 60 100 60 90 40 Florida 24,200 245 1,900 3,100 6,600 450 400 1,500 800 1,200 750 Georgie 8,200 152 650 800 2,200 200 250 450 225 425 300 Hawaii 1,200 126 75 150 300 30 20 40 90 60 50 Idaho 1,300 143 100 150 300 25 25 90 40 70 70 lilinois 21,900 194 2,000 3,100 5,400 500 600 1,200 750 1,200 900 l Indiana 9,700 180 900 1,400 2,500 200 300 500 250 500 400 lows 5,700 196 500 900 1,300 100 125 350 150 325 275
. Kansas 4,400 189 425 550 1,100 100 100 300 125 250 200
! Kentucky 6,700 475 850 2,000 175 175 400 150 350 275 Louisiana 7,300 550 750 2,000 175 175 400 250 375 250
- '1 t Maine 2,300 200 350 550 50 60 125 90 100 80 0
Maryland 8,000 181 700 1,000 2,100 200 175 425 225 375 250 Massachusetts 11,900 198 1,200 1,800 2,700 325 275 600 500 600 425 Michigen 16,000 172 1,400 2,100 4,100 325 400 850 475 800 600 Minnesote 7,000 173 650 1,000 1,400 150 125 475 250 400 325 Mississippi 4,300 176 300 425 1,200 90 100 325 125 275 200 Missouri 9,700 190 800 1,400 2,500 200 250 600 275 475 400 Montana 1,300 162 100 175 300 30 30 100 50 80 60 Nebraska 3,000 186 275 450 650 60 70 200 125 175 150 Nevada 1,200 178 80 125 350 25 20 50 10 60 30 New Hempshire 1,700 193 150 275 400 40 40 90 40 80 70 New Jersey 15,900 211 1,600 2,400 3,800 350 375 750 650 800 500 New Mexico 1,600 126 125 200 350 25 40 80 50 80 50 New York 37,400 209 4,000 5,800 8,600 850 950 1,800 1,600 2,100 1,400 North Carolina 9,800 167 750 1,000 2,400 225 275 550 250 450 375 North Dakota 1,100 167 90 150 200 20 20 00 60 80 50
, Ohio 21,000 195 1,900 2,900 5,500 425 600 1,100 650 1,000 800 Oklahome 5,700 198 400 650 1,600 100 100 325 150 300 225 Oregon 4,600 186 375 500 1.300 100 75 300 125 250 200 Pennsylvania 25,200 212 2,400 3,900 5,900 500 700 1,300 850 1,300 950 Rhode Island 2,400 247 250 400 550 60 40 125 100 100 60 South Caroline 4,800 156 375 450 1,300 100 125 300 125 275 175 South Dakota 1,300 188 100 200 300 20 30 100 50 90 80 Tennessee 8,500 193 600 900 2,300 200 200 450 225 425 300 Texas 21,400 160 1,700 2,400 5,600 425 500 1,100 700 1,200 1,000 Utah 1,500 111 150 175 225 20 30 100 50 75 60 Vermont 950 191 80 150 250 20 30 60 30 50 40 Virginia 8,700 161 750 1,000 2,300 175 225 450 250 425 300 Washington 7,100 193 600 850 1,800 150 150 425 200 375 275 West Virginia 3,800 205 275 450 1,000 75 100 200 100 200 125 Wisconsin 8,700 181 900 1,200 1,800 175 175 500 325 450 350 Wyoming 650 157 50 70 175 10 10 40 15 40 20 United States Puerto Rico 420,000 3,000 (M 96 37,000 125 55,000 105,000 9,000 225 300 175 10,000 150 23,000 225 14,000 22,000 16,000 400 100 150 10 b
- UNITED STATES OF AMERICA NUCLEAR REGULATORY C0"J41SSION BEFORE THE ATOMIC SAFETY AND LICENSING BOARD In the Matter of )
)
LOUISIANA POWER AND LIGHT COMPANY ) Docket No. 50-382
)
(Waterford Steam Electric Station, )
Unit 3) .
)
CERTIFICATE OF SERVICE I hereby certify that copies of "NRC STAFF'S SUPPLEMENTAL MOTION TO CORRECT THE HEARING TRANSCRIPT" in the above-captioned proceeding have been served on the following by deposit in the United States mail, first class or, as indicated by an asterisk, through deposit in the Nuclear Regulatory Commission's -
internal mail system, this 16th day of July,1982.
- Sheldon J. Wolfe, Esq., Chairman Luke B. Fontana, Esq.
Administrative Judge 824 Esplanade Avenue Atomic Safety and Licensing Board New Orleans, LA 70116 U.S. Nuclear Regulatory Commission Washington, DC 20555 Malcolm Stevenson, Esq.
Monroe & Lemann Dr. Water H. Jordan 1424 Whitney Building Administrative Judge New Orleans, LA 70130 881 West Outer Drive Oak Ridge, TN 37830
- Atomic Safety and Licensing Board Panel Dr. Harry Foreman U.S. Nuclear Regulatory Commission Administrative Judge Washington, DC 20555 Box 395, Mayo Minneapolis, MN 55455
- Atomic Safety and Licensing Appeal Board Panel E. Blake, Esq. U.S. Nuclear Regulatory Commission B. Churchill, Esq. Washington, DC 20555 Shaw, Pittman, Potts & Trowbridge 1800 M Street, N.W.
- Docketing and Service Section Washington, DC 20036 Office of the Secretary U.S. Nuclear Regulatory Commission Mr. Gary L. Groesch Washington, DC 20555 2257 Bayou Road New Orleans, LA 70119 Sherwin E. Turk Counsel for NRC Staff